Successful Administration of Iron Sucrose in a Patient with an Anaphylactic Reaction to Ferric Carboxymaltose

  • Sanjay VikrantEmail author
  • Ajay Jaryal


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Rognoni C, Venturini S, Meregaglia M, Marmifero M, Tarricone R (2016) Efficacy and safety of ferric carboxymaltose and other formulations in iron-deficient patients: a systematic review and network meta-analysis of randomised controlled trials. Clin Drug Investig 36:177–194CrossRefGoogle Scholar
  2. 2.
    Venofer prescribing information. Accessed 8 Jun 2016
  3. 3.
    Vikrant S (2007) Optimum dosage regimen for iron sucrose. Kidney Int 72:225CrossRefGoogle Scholar
  4. 4.
    Wang C, Graham DJ, Kane RC et al (2015) Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 314:2062–2068CrossRefGoogle Scholar
  5. 5.
    Haddad A, Abbadi R, Marji A (2009) Use of iron sucrose in dialysis patients sensitive to iron dextran. Saudi J Kidney Dis Transpl 20:208–211Google Scholar
  6. 6.
    Sane R, Baribeault D, Rosenberg CL (2007) Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. Pharmacotherapy 27:613–615CrossRefGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2018

Authors and Affiliations

  1. 1.Department of NephrologyIndira Gandhi Medical CollegeShimlaIndia

Personalised recommendations